You appear to be offline. Some data may be unavailable until your connection is restored.
CRL
StockCharles River Laboratories International Inc
Price data not available
Description
Charles River Laboratories International Inc. is a global contract research organization that supplies preclinical drug development services, including custom research models, in‑vitro and in‑vivo safety testing, and manufacturing support such as microbial and biologics testing solutions. It serves pharmaceutical, biotechnology, academic and government customers across the life‑sciences and healthcare sectors. The company operates through three primary segments—Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions—providing a broad portfolio that spans from animal and cell models to regulated non‑clinical testing. With a presence in North America, Europe and Asia, Charles River holds a leading market position in non‑clinical CRO services and is known for its extensive model libraries and high‑quality, regulatory‑focused capabilities.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Feb 3, 2027 (est.) | — |
| Q3 FY26 | Nov 4, 2026 | $3.09 |
| Q2 FY26 | Aug 5, 2026 | $3.02 |
| Q1 FY26 | May 7, 2026 | $2.06 |
| Q4 FY25 | Feb 18, 2026 | $2.39 |
Stay ahead of CRL earnings
Get reminders ahead of CRL's next earnings report, so you always know when results are coming.